(Q36497118)

English

Fibroblast growth factor-4 and hepatocyte growth factor induce differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocytes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Fibroblast growth factor-4 and hepatocyte growth factor induce differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocytes (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

human umbilical cord mesenchymal stem cell

1 reference

based on heuristic

inferred from title

author name string

Xin-Qin Kang

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Wei-Jin Zang

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Li-Jun Bao

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Dong-Ling Li

4

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Tu-Sheng Song

5

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Xiao-Li Xu

6

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Xiao-Jiang Yu

7

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

language of work or name

0 references

publication date

1 December 2005

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

World Journal of Gastroenterology

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

11

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

47

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

7461-7465

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Rat bone marrow mesenchymal stem cells differentiate into hepatocytes in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725161

30 September 2017

Mesenchymal stem cells from cryopreserved human umbilical cord blood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725161

30 September 2017

Long-term culture and differentiation of rat embryonic stem cell-like cells into neuronal, glial, endothelial, and hepatic lineages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725161

30 September 2017

Proliferation and differentiation of osteoblasts and adipocytes in rat bone marrow stromal cell cultures: Effects of dexamethasone and calcitriol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725161

30 September 2017

Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725161

30 September 2017

Human BMP-7/OP-1 induces the growth and differentiation of adipocytes and osteoblasts in bone marrow stromal cell cultures.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725161

30 September 2017

Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725161

30 September 2017

Bone marrow cells regenerate infarcted myocardium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725161

30 September 2017

Reciprocal control of osteoblast/chondroblast and osteoblast/adipocyte differentiation of multipotential clonal human marrow stromal F/STRO-1(+) cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725161

30 September 2017

Comparison of different methods for separation and ex vivo expansion of cord blood progenitor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725161

30 September 2017

Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725161

30 September 2017

Arginase activity in endothelial cells: inhibition by NG-hydroxy-L-arginine during high-output NO production

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725161

28 June 2018

Differential gene expression profiling of human umbilical cord blood-derived mesenchymal stem cells by DNA microarray.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725161

21 September 2018

A modified cord blood collection method achieves sufficient cell levels for transplantation in most adult patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725161

21 September 2018

Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725161

21 September 2018

Mesenchymal stem/progenitor cells developed in cultures from UC blood.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725161

21 September 2018

Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725161

21 September 2018

Expression of brain natriuretic peptide by human bone marrow stromal cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725161

21 September 2018

Cell death and long-term maintenance of neuron-like state after differentiation of rat bone marrow stromal cells: a comparison of protocols

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725161

21 September 2018

Differentiation potential of a mouse bone marrow stromal cell line.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725161

21 September 2018

Effect of dexamethasone withdrawal on osteoblastic differentiation of bone marrow stromal cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725161

21 September 2018

The effect of bone marrow stromal cells on neuronal differentiation of mesencephalic neural stem cells in Sprague-Dawley rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725161

21 September 2018

Liver-specific gene expression in cultured human hematopoietic stem cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725161

21 September 2018

Phenotypic effects of continuous or discontinuous treatment with dexamethasone and/or calcitriol on osteoblasts differentiated from rat bone marrow stromal cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725161

21 September 2018

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Hepatocellular carcinoma: diagnosis and treatment

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Chemoembolization for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Hepatocellular carcinoma: recent trends in Japan.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Hepatocellular carcinoma: recent trends in the United States

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Genetic aspects of hepatocellular carcinogenesis

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Molecular mechanisms underlying the development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Molecular viral oncology of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

An update on the molecular genetics of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Telomeres and telomerase: a dual role in hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Environmental factors and risk for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Immune pathogenesis of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Prevention of hepatocellular carcinoma development associated with chronic hepatitis by anti-fas ligand antibody therapy

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: multistage hepatocarcinogenesis with multifactorial etiology

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Diagnosis and staging of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Selection of candidates with HCC for transplantation in the MELD era.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Adult-to-adult transplantation of the right hepatic lobe from a living donor

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: long-term survival in the experience of a single radiologic referral center

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Thermal ablation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Complications of radiofrequency coagulation of liver tumours

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach".

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Intraarterial HCC therapy with I-131-Lipiodol

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

External beam radiation therapy for hepatocellular carcinoma: potential of intensity-modulated and image-guided radiation therapy

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis?

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Low-dose thalidomide treatment for advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Gene therapy for malignant liver disease

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Immunobiology and gene-based immunotherapy of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Antibody-directed therapy for human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Immunotherapeutic strategies for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Prevention of hepatitis C virus-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Prevention of hepatitis B virus-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Epidermal powder immunization induces both cytotoxic T-lymphocyte and antibody responses to protein antigens of influenza and hepatitis B viruses

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Production of hepatitis B surface antigen in transgenic plants for oral immunization

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Vaccination of chimpanzees against infection by the hepatitis C virus

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Hepatitis C virus-like particles induce virus-specific humoral and cellular immune responses in mice

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Priming of hepatitis C virus-specific cytotoxic T lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Different hepatitis C virus nonstructural protein 3 (Ns3)-DNA-expressing vaccines induce in HLA-A2.1 transgenic mice stable cytotoxic T lymphocytes that target one major epitope

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Oral immunization with HCV-NS3-transformed Salmonella: induction of HCV-specific CTL in a transgenic mouse model

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Treatment of acute hepatitis C with interferon alfa-2b

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Chronic hepatitis B virus infection: treatment strategies for the next millennium

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Management of hepatitis B: 2000--summary of a workshop

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Lamivudine for patients with chronic hepatitis B and advanced liver disease

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Effect of the dose and duration of interferon-alpha therapy on the incidence of hepatocellular carcinoma in noncirrhotic patients with a nonsustained response to interferon for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus-an analysis of 236 consecutive patients with a single lesion

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Unresectable Hepatocellular Carcinoma: Meta-Analysis of Arterial Embolization [letter]

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

An inflammatory link

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I47.7391

21 January 2018

Isolation of multipotent mesenchymal stem cells from umbilical cord blood

1 reference

https://pubmed.ncbi.nlm.nih.gov/16437717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adult bone marrow stem cells regenerate myocardium in ischemic heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16437717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/16437717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of Umbilical Cord Blood Mesenchymal Stem Cells into Neuron-Like Cells In Vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/16437717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/16437717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of neural markers nestin and GFAP expression by cultivated bone marrow stromal cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16437717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3748/WJG.V11.I47.7391

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36497118&oldid=1635467594"